BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 27869069)

  • 1. [Unusual phenotype of myopathy associated with a new PNPLA2 mutation].
    Jousserand G; Streichenberger N; Petiot P
    Med Sci (Paris); 2016 Nov; 32 Hors série n°2():10-11. PubMed ID: 27869069
    [No Abstract]   [Full Text] [Related]  

  • 2. A novel mutation in PNPLA2 causes neutral lipid storage disease with myopathy and triglyceride deposit cardiomyovasculopathy: a case report and literature review.
    Kaneko K; Kuroda H; Izumi R; Tateyama M; Kato M; Sugimura K; Sakata Y; Ikeda Y; Hirano K; Aoki M
    Neuromuscul Disord; 2014 Jul; 24(7):634-41. PubMed ID: 24836204
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Late onset of neutral lipid storage disease due to novel PNPLA2 mutations causing total loss of lipase activity in a patient with myopathy and slight cardiac involvement.
    Missaglia S; Maggi L; Mora M; Gibertini S; Blasevich F; Agostoni P; Moro L; Cassandrini D; Santorelli FM; Gerevini S; Tavian D
    Neuromuscul Disord; 2017 May; 27(5):481-486. PubMed ID: 28258942
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A myopathy with unusual features caused by PNPLA2 gene mutations.
    Pennisi EM; Missaglia S; Dimauro S; Bernardi C; Akman HO; Tavian D
    Muscle Nerve; 2015 Apr; 51(4):609-13. PubMed ID: 25287355
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Late onset of neutral lipid storage disease due to a rare PNPLA2 mutation in a patient with myopathy and cardiomyopathy.
    Tian Y; Wang S; Wang F; Yi L; Dong M; Huang X
    Chin Med J (Engl); 2022 Oct; 135(19):2389-2391. PubMed ID: 36535014
    [No Abstract]   [Full Text] [Related]  

  • 6. Novel PNPLA2 gene mutation in a child causing neutral lipid storage disease with myopathy.
    Zheng S; Liao W
    BMC Med Genet; 2018 Sep; 19(1):172. PubMed ID: 30223778
    [TBL] [Abstract][Full Text] [Related]  

  • 7. PNPLA2 mutation: a paediatric case with early onset but indolent course.
    Perrin L; Féasson L; Furby A; Laforêt P; Petit FM; Gautheron V; Chabrier S
    Neuromuscul Disord; 2013 Dec; 23(12):986-91. PubMed ID: 24074500
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Subclinical myopathy in a child with neutral lipid storage disease and mutations in the PNPLA2 gene.
    Fiorillo C; Brisca G; Cassandrini D; Scapolan S; Astrea G; Valle M; Scuderi F; Trucco F; Natali A; Magnano G; Gazzerro E; Minetti C; Arca M; Santorelli FM; Bruno C
    Biochem Biophys Res Commun; 2013 Jan; 430(1):241-4. PubMed ID: 23146629
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neutral lipid-storage disease with myopathy and extended phenotype with novel PNPLA2 mutation.
    Massa R; Pozzessere S; Rastelli E; Serra L; Terracciano C; Gibellini M; Bozzali M; Arca M
    Muscle Nerve; 2016 Apr; 53(4):644-8. PubMed ID: 26600210
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A novel mutation in PNPLA2 leading to neutral lipid storage disease with myopathy.
    Ash DB; Papadimitriou D; Hays AP; Dimauro S; Hirano M
    Arch Neurol; 2012 Sep; 69(9):1190-2. PubMed ID: 22964912
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A novel PNPLA2 mutation causes neutral lipid storage disease with myopathy (NLSDM) presenting muscular dystrophic features with lipid storage and rimmed vacuoles.
    Chen J; Hong D; Wang Z; Yuan Y
    Clin Neuropathol; 2010; 29(6):351-6. PubMed ID: 21073837
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Novel PNPLA2 gene mutations in Chinese Han patients causing neutral lipid storage disease with myopathy.
    Lin P; Li W; Wen B; Zhao Y; Fenster DS; Wang Y; Gong Y; Yan C
    J Hum Genet; 2012 Oct; 57(10):679-81. PubMed ID: 22832386
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neutral lipid storage disease with myopathy: Further phenotypic characterization of a rare PNPLA2 variant.
    Latimer CS; Schleit J; Reynolds A; Marshall DA; Podemski B; Wang LH; Gonzalez-Cuyar LF
    Neuromuscul Disord; 2018 Jul; 28(7):606-609. PubMed ID: 29779757
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Novel duplication mutation in the patatin domain of adipose triglyceride lipase (PNPLA2) in neutral lipid storage disease with severe myopathy.
    Akiyama M; Sakai K; Ogawa M; McMillan JR; Sawamura D; Shimizu H
    Muscle Nerve; 2007 Dec; 36(6):856-9. PubMed ID: 17657808
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Patients with neutral lipid storage disease with myopathy (NLSDM) in Southwestern China.
    Tan J; Yang H; Fan J; Fan Y; Xiao F
    Clin Neurol Neurosurg; 2018 May; 168():102-107. PubMed ID: 29539587
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The phenotypic spectrum of neutral lipid storage myopathy due to mutations in the PNPLA2 gene.
    Reilich P; Horvath R; Krause S; Schramm N; Turnbull DM; Trenell M; Hollingsworth KG; Gorman GS; Hans VH; Reimann J; MacMillan A; Turner L; Schollen A; Witte G; Czermin B; Holinski-Feder E; Walter MC; Schoser B; Lochmüller H
    J Neurol; 2011 Nov; 258(11):1987-97. PubMed ID: 21544567
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neutral lipid storage disease with myopathy and dropped head syndrome. Report of a new variant susceptible of treatment with late diagnosis.
    Garcia MA; Rojas JA; Millán SP; Flórez AA
    J Clin Neurosci; 2018 Dec; 58():207-209. PubMed ID: 30352762
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neutral lipid storage disease with myopathy with a novel homozygous PNPLA2 variant.
    Yamada K; Yaguchi H; Abe M; Ishikawa K; Tanaka D; Oshima Y; Kudo A; Uwatoko H; Shirai S; Takahashi-Iwata I; Matsushima M; Nishino I; Yabe I
    Clin Neurol Neurosurg; 2023 May; 228():107670. PubMed ID: 36996668
    [No Abstract]   [Full Text] [Related]  

  • 19. Neutral Lipid Storage Disease Associated with the PNPLA2 Gene: Case Report and Literature Review.
    Samukawa M; Nakamura N; Hirano M; Morikawa M; Sakata H; Nishino I; Izumi R; Suzuki N; Kuroda H; Shiga K; Saigoh K; Aoki M; Kusunoki S
    Eur Neurol; 2020; 83(3):317-322. PubMed ID: 32564019
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of bezafibrate treatment in a patient and a carrier with mutations in the PNPLA2 gene, causing neutral lipid storage disease with myopathy.
    van de Weijer T; Havekes B; Bilet L; Hoeks J; Sparks L; Bosma M; Paglialunga S; Jorgensen J; Janssen MC; Schaart G; Sauerwein H; Smeets JL; Wildberger J; Zechner R; Schrauwen-Hinderling VB; Hesselink MK; Schrauwen P
    Circ Res; 2013 Mar; 112(5):e51-4. PubMed ID: 23449549
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.